Norvir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Redpharm Drug, Inc.. The primary component is Ritonavir.
Product ID | 67296-1234_4f314d1a-237b-464f-e054-00144ff8d46c |
NDC | 67296-1234 |
Product Type | Human Prescription Drug |
Proprietary Name | Norvir |
Generic Name | Norvir |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2010-05-06 |
Marketing Category | NDA / NDA |
Application Number | NDA022417 |
Labeler Name | RedPharm Drug, Inc. |
Substance Name | RITONAVIR |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2010-05-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022417 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-05-06 |
Ingredient | Strength |
---|---|
RITONAVIR | 100 mg/1 |
SPL SET ID: | 4f314d1a-237a-464f-e054-00144ff8d46c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0074-1940 | Norvir | Ritonavir |
0074-2340 | Norvir | Ritonavir |
0074-3333 | Norvir | Ritonavir |
0074-3399 | Norvir | Ritonavir |
50090-1162 | Norvir | Ritonavir |
53808-1119 | Norvir | Ritonavir |
67296-1234 | Norvir | Norvir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NORVIR 74655713 2001944 Live/Registered |
ABBVIE INC. 1995-04-04 |